---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-029969"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2023-08-23T23:59:59+00:00"
generated_at: "2026-06-11T04:40:38.007345+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix extends distribution pact with largest distributor UPPI, secures purchase guarantees through 2023

## Summary
- Extends exclusive distribution of PainShield and PainShield Plus to UPPI for DME sector in the US.
- Immediate re-stocking order and minimum purchase guarantees through end of 2023.
- Term runs 12 months or until CMS assigns reimbursement value, whichever comes first.
- CMS application submitted March 2023; reimbursements could start as early as October 1, 2023 if approved.
- UPPI is NanoVibronix's largest PainShield distributor.

## SEC filing metadata
- accession: 0001493152-23-029969
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2023-08-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315223029969/0001493152-23-029969-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315223029969/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-029969
- JSON: https://secwatch.observer/filing/0001493152-23-029969.json
- Plain text: https://secwatch.observer/filing/0001493152-23-029969.txt

## Key facts
- Material Agreements
  ENvue Medical, Inc. amended Amended and Restated Distribution Agreement for private labeled products with Ultra Pain Products Inc. valued at Amendment to exclusive distribution agreement for PainShield and PainShield Plus devices; includes r (effective 2023-08-11).
  - Action: amendment
  - Agreement: supply
  - Counterparty: Ultra Pain Products Inc.
  - Value: Amendment to exclusive distribution agreement for PainShield and PainShield Plus devices; includes r
  - Effective: 2023-08-11
  source text: On August 22, 2023, NanoVibronix, Inc. (the “ Company ”), entered into a second amendment (the “Amendment”) to the Amended and Restated Distribution Agreement for private labeled products, dated December 10, 2020 (as amended by the Amendment, the “ Agreement ”), between the Company and Ultra Pain Products Inc. (“ UPPI ”), effective as of August 11, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000149315223029969/0001493152-23-029969-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.